Literature DB >> 8521298

Antiviral drugs from the nucleoside analog family block volume-activated chloride channels.

M Gschwentner1, A Susanna, E Wöll, M Ritter, U O Nagl, A Schmarda, A Laich, G M Pinggera, H Ellemunter, H Huemer.   

Abstract

BACKGROUND: The antiviral drugs AZT and acyclovir are generally used in the treatment of infections with human immunodeficiency virus (HIV) and herpes simplex virus (HSV). These substances are known to impede virus replication by premature nucleic acid chain termination. It is not yet clear, however, if this is the sole mechanism responsible for the antiviral and/or the numerous side effects observed in patients treated with these agents. We investigated the swelling-induced chloride current in fibroblasts, which we demonstrated is closely related or identical to a cloned epithelial chloride channel, ICln: This chloride channel can be blocked by nucleotides.
MATERIALS AND METHODS: Electrophysiological, fluorescence optical, and volume measurements were made to determine the effect of nucleoside analogs on the swelling-dependent chloride current (ICl) in NIH 3T3 fibroblasts and in human T cell lymphoma (H9) cells and the cAMP-dependent chloride current in CaCo cells.
RESULTS: AZT and acyclovir block the swelling-dependent chloride current and the chloride flux in fibroblasts, and the regulatory volume decrease (RVD) and ICl in H9 cells. This immediate effect can be substantially reduced by the simultaneous incubation of the cells with thymidine-5'-diphosphate (TDP) or uridine, both of which are by themselves unable to affect ICl.
CONCLUSIONS: We show here a novel molecular mechanism by which antiviral drugs of the nucleoside analog family could lead to impairments of the kidney, bone marrow, gastrointestinal, and neuronal functions, and how these side effects could possibly be restricted by the presence of TDP or uridine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521298      PMCID: PMC2229993     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  25 in total

1.  Direct visualisation and quantification of cellular cytotoxicity using two colour flourescence.

Authors:  B J Kroesen; G Mesander; J G ter Haar; T H The; L de Leij
Journal:  J Immunol Methods       Date:  1992-11-25       Impact factor: 2.303

2.  New mammalian chloride channel identified by expression cloning.

Authors:  M Paulmichl; Y Li; K Wickman; M Ackerman; E Peralta; D Clapham
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

3.  Inhibition of ion conductances by osmotic shrinkage of Madin-Darby canine kidney cells.

Authors:  M Ritter; M Steidl; F Lang
Journal:  Am J Physiol       Date:  1991-10

Review 4.  The biological significance of cell volume.

Authors:  F Lang; M Ritter; H Völkl; D Häussinger
Journal:  Ren Physiol Biochem       Date:  1993 Jan-Apr

5.  Characterization of a Ca(2+)-dependent anion channel from sheep tracheal epithelium incorporated into planar bilayers.

Authors:  E W Alton; S D Manning; P J Schlatter; D M Geddes; A J Williams
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

Review 6.  Ca2(+)-activated cell volume recovery mechanisms.

Authors:  S K Pierce; A D Politis
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

7.  Cell cycle dependence of chloride permeability in normal and cystic fibrosis lymphocytes.

Authors:  J K Bubien; K L Kirk; T A Rado; R A Frizzell
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

8.  Cutaneous manifestations of measles in AIDS.

Authors:  N S McNutt; S Kindel; J Lugo
Journal:  J Cutan Pathol       Date:  1992-08       Impact factor: 1.587

9.  Development of spongiform encephalopathy in retroviral infected mice.

Authors:  R M Nagra; P G Burrola; C A Wiley
Journal:  Lab Invest       Date:  1992-03       Impact factor: 5.662

10.  Trinitrophenyl-ATP blocks colonic Cl- channels in planar phospholipid bilayers. Evidence for two nucleotide binding sites.

Authors:  C J Venglarik; A K Singh; R Wang; R J Bridges
Journal:  J Gen Physiol       Date:  1993-04       Impact factor: 4.086

View more
  6 in total

1.  Fluorescence-optical measurements of chloride movements in cells using the membrane-permeable dye diH-MEQ.

Authors:  E Wöll; M Gschwentner; J Fürst; S Hofer; G Buemberger; A Jungwirth; J Frick; P Deetjen; M Paulmichl
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

2.  Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA).

Authors:  Jessica L Reynolds; Supriya D Mahajan; Donald Sykes; Madhavan P N Nair
Journal:  Am J Infect Dis       Date:  2006

3.  The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels.

Authors:  A Schmarda; P Dinkhauser; M Gschwentner; M Ritter; J Fürst; E Scandella; E Wöll; A Laich; H Rossmann; U Seidler; F Lang; M Paulmichl
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Blockade of swelling-induced chloride channels by phenol derivatives.

Authors:  M Gschwentner; A Jungwirth; S Hofer; E Wöll; M Ritter; A Susanna; A Schmarda; G Reibnegger; G M Pinggera; M Leitinger; J Frick; P Deetjen; M Paulmichl
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

5.  The molecular and functional interaction between ICln and HSPC038 proteins modulates the regulation of cell volume.

Authors:  Silvia Dossena; Rosaria Gandini; Grazia Tamma; Valeria Vezzoli; Charity Nofziger; Margherita Tamplenizza; Elisabetta Salvioni; Emanuele Bernardinelli; Giuliano Meyer; Giovanna Valenti; Magnus Wolf-Watz; Johannes Fürst; Markus Paulmichl
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

Review 6.  Cell Death Induction and Protection by Activation of Ubiquitously Expressed Anion/Cation Channels. Part 1: Roles of VSOR/VRAC in Cell Volume Regulation, Release of Double-Edged Signals and Apoptotic/Necrotic Cell Death.

Authors:  Yasunobu Okada; Ravshan Z Sabirov; Kaori Sato-Numata; Tomohiro Numata
Journal:  Front Cell Dev Biol       Date:  2021-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.